South San Francisco, California Clinical Trials

A listing of South San Francisco, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

University of California San Francisco (UCSF)
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease (RESULT)

This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD).The purpose of this study is to measure the change in proteinuria and its impact on the rates of remission of nephrotic syndrome with frexalimab, SAR442970, or …

Investigational Site Number : 8400012
 (8.0 away) Contact site
  • 0 views
  • 20 Jun, 2025
  • +24 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

absolute neutrophil count
squamous non-small cell lung cancer
stage iia lung squamous cell carcinoma ajcc v7
squamous non-small cell lung carcinoma
EGFR
Mills-Peninsula Medical Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

alzheimer's disease
positron emission tomography
mini-mental state examination
flortaucipir
florbetapir
Univ of California San Francisco
 (8.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
progranulin
pick's disease
dementia
University of California San Francisco
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
Family Telehealth Project for Foster Care Youth

The purpose of this research is to adapt and evaluate the efficacy of an existing family based intervention to be delivered via telehealth to child welfare-involved (CWI) youth in out-of-home placement and their caregiver of origin.

family based
cognitive impairment
UCSF Zuckerberg San Francisco General Hospital
 (6.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Liberation From Acute Dialysis

The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge for how to guide delivery of dialysis to …

intermittent hemodialysis
renal replacement
glomerular filtration rate
vasoconstrictor
acute tubular necrosis
University of Califonia, San Francisco
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Localized Renal Tumor

This feasibility study will evaluate how well hyperpolarized 13C pyruvate magnetic resonance imaging (MRI) scan works in predicting tumor aggressiveness in patients with localized renal tumor. Hyperpolarized 13C pyruvate is a non-radioactive substance with potential usage in the diagnostic imaging of tumors. Hyperpolarized 13C pyruvate MRI may help doctors determine …

aggressiveness
renal neoplasm
abdominal mri
MRI
estimated creatinine clearance
University of California, San Francisco
 (9.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Using Technology to Reduce Youth Substance Use

The research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.

UCSF Zuckerberg San Francisco General Hospital
 (6.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

regurgitation
shortness of breath
fatigue
aortic valve replacement
California Pacific Medical Center Research Institute
 (9.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations